BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 35058180)

  • 1. Deep phenotyping of surface stimulatory and inhibitory co-receptors on cancer-resident T and NK cells reveals cell subsets within the tumor-reactive CTL population that are uniquely defined by NKG2A expression.
    Hair J; Robinson MJ; Wilkinson RW; Dovedi SJ
    SLAS Discov; 2022 Mar; 27(2):95-106. PubMed ID: 35058180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduction of immunosuppressive tumor microenvironment in cholangiocarcinoma by ex vivo targeting immune checkpoint molecules.
    Zhou G; Sprengers D; Mancham S; Erkens R; Boor PPC; van Beek AA; Doukas M; Noordam L; Campos Carrascosa L; de Ruiter V; van Leeuwen RWF; Polak WG; de Jonge J; Groot Koerkamp B; van Rosmalen B; van Gulik TM; Verheij J; IJzermans JNM; Bruno MJ; Kwekkeboom J
    J Hepatol; 2019 Oct; 71(4):753-762. PubMed ID: 31195061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased natural killer cell subsets with inhibitory cytokines and inhibitory surface receptors in patients with recurrent miscarriage and decreased or normal subsets in kidney transplant recipients late post-transplant.
    Zhu L; Aly M; Wang H; Karakizlis H; Weimer R; Morath C; Kuon RJ; Toth B; Ekpoom N; Opelz G; Daniel V
    Clin Exp Immunol; 2018 Aug; 193(2):241-254. PubMed ID: 29679490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD8
    Chen Y; Xin Z; Huang L; Zhao L; Wang S; Cheng J; Wu P; Chai Y
    Front Immunol; 2019; 10():3002. PubMed ID: 32010126
    [No Abstract]   [Full Text] [Related]  

  • 5. Deep phenotyping characterization of human unconventional CD8
    Orta-Resendiz A; Petitdemange C; Schmutz S; Jacquelin B; Novault S; Huot N; Müller-Trutwin M
    STAR Protoc; 2023 Dec; 4(4):102734. PubMed ID: 38032799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Up-regulation of inhibitory natural killer receptors CD94/NKG2A with suppressed intracellular perforin expression of tumor-infiltrating CD8+ T lymphocytes in human cervical carcinoma.
    Sheu BC; Chiou SH; Lin HH; Chow SN; Huang SC; Ho HN; Hsu SM
    Cancer Res; 2005 Apr; 65(7):2921-9. PubMed ID: 15805295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sister cytotoxic CD8+ T cell clones differing in natural killer inhibitory receptor expression in human astrocytoma.
    Perrin G; Speiser D; Porret A; Quiquerez AL; Walker PR; Dietrich PY
    Immunol Lett; 2002 Apr; 81(2):125-32. PubMed ID: 11852117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential disappearance of inhibitory natural killer cell receptors during HAART and possible impairment of HIV-1-specific CD8 cytotoxic T lymphocytes.
    Costa P; Rusconi S; Mavilio D; Fogli M; Murdaca G; Pende D; Mingari MC; Galli M; Moretta L; De Maria A
    AIDS; 2001 May; 15(8):965-74. PubMed ID: 11399978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered CD94/NKG2A and perforin expression reduce the cytotoxic activity in malignant pleural effusions.
    Pace E; Di Sano C; Ferraro M; Tipa A; Olivieri D; Spatafora M; Santagata R; Bellia V; Gjomarkaj M
    Eur J Cancer; 2011 Jan; 47(2):296-304. PubMed ID: 20932742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancing Natural Killer and CD8
    Ravindranath MH; Filippone EJ; Devarajan A; Asgharzadeh S
    Monoclon Antib Immunodiagn Immunother; 2019 Apr; 38(2):38-59. PubMed ID: 31009335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenotype, cytokine production and cytolytic capacity of fresh (uncultured) tumour-infiltrating T lymphocytes in human renal cell carcinoma.
    Van den Hove LE; Van Gool SW; Van Poppel H; Baert L; Coorevits L; Van Damme B; Ceuppens JL
    Clin Exp Immunol; 1997 Sep; 109(3):501-9. PubMed ID: 9328129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assay of T- and NK-cell subsets and the expression of NKG2A and NKG2D in patients with new-onset systemic lupus erythematosus.
    Li WX; Pan HF; Hu JL; Wang CZ; Zhang N; Li J; Li XP; Xu JH; Ye DQ
    Clin Rheumatol; 2010 Mar; 29(3):315-23. PubMed ID: 20012119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural Killer Group 2A Expressed on Both Peripheral CD3
    Yi RT; Niu YH; Liu HL; Zhang TY; Yang YC; Zhang Y; Yin DL; Chen TY; Zhao YR
    J Interferon Cytokine Res; 2016 Dec; 36(12):689-697. PubMed ID: 27828717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional phenotyping of circulating human cytotoxic T cells and NK cells using a 16-color flow cytometry panel.
    Baracho GV; Kara N; Rigaud S; Lo E; Widmann SJ; Tyznik AJ
    STAR Protoc; 2022 Mar; 3(1):101069. PubMed ID: 35024627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo expression of natural killer cell inhibitory receptors by human melanoma-specific cytolytic T lymphocytes.
    Speiser DE; Pittet MJ; Valmori D; Dunbar R; Rimoldi D; Liénard D; MacDonald HR; Cerottini JC; Cerundolo V; Romero P
    J Exp Med; 1999 Sep; 190(6):775-82. PubMed ID: 10499916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of NKG2A inhibitory receptor on cytotoxic lymphocytes as an indicator of severity in Corona Virus Disease 2019 (COVID-19) patients.
    Yasin MM; Shehata IH; Elsheikh NG; Elsayed MS
    Egypt J Immunol; 2021 Jul; 28(3):157-167. PubMed ID: 34453787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The natural killer cell-like lytic activity expressed by cytolytic T lymphocytes is associated with the expression of a novel function-associated molecule.
    Harris DT; Jaso-Friedmann L; Devlin RB; Koren HS; Evans DL
    Scand J Immunol; 1992 Mar; 35(3):299-309. PubMed ID: 1531548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor specific cytolysis by tumor infiltrating lymphocytes in breast cancer.
    Baxevanis CN; Dedoussis GV; Papadopoulos NG; Missitzis I; Stathopoulos GP; Papamichail M
    Cancer; 1994 Aug; 74(4):1275-82. PubMed ID: 7914469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of antigen-induced T cell response and antibody-induced NK cell cytotoxicity by NKG2A: association of NKG2A with SHP-1 and SHP-2 protein-tyrosine phosphatases.
    Le Dréan E; Vély F; Olcese L; Cambiaggi A; Guia S; Krystal G; Gervois N; Moretta A; Jotereau F; Vivier E
    Eur J Immunol; 1998 Jan; 28(1):264-76. PubMed ID: 9485206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential susceptibility of leukocyte subsets to cytotoxic T cell killing: implications for HIV immunopathogenesis.
    Liu J; Roederer M
    Cytometry A; 2007 Feb; 71(2):94-104. PubMed ID: 17200952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.